Cancer Diagnosis News and Research

RSS

Men with asthma less likely to develop lethal prostate cancer

Scientists found that men with a history of asthma were 29 percent less likely to have been diagnosed with prostate cancer that spread or to have died of their prostate cancer...

14 May 2015

Managing cancer at work: Johns Hopkins launches new service for all employees

Johns Hopkins Medicine has created and launched Managing Cancer at Work, a new and novel health benefit program offered free of charge for its more than 42,000 combined full-time equivalent employees.

12 May 2015

Childhood cancer survivors more likely to be obese than healthy peers

Childhood cancer survivors - especially those whose treatment included brain irradiation or chemotherapy with glucocorticoids - are 14 percent more likely to be obese than their healthy peers.

12 May 2015

Leicester research team identifies potential new targets for cancer treatments

An international consortium of scientists led by a group from the University of Leicester has announced a new advance in understanding the mechanisms of cancer and how to target it more effectively with new treatments...

12 May 2015

The Project Data Sphere® initiative achieves 1st year milestones

Cancer community broadly shares, integrates, and analyzes clinical trial data within a single research platform to advance innovation and improve lives...

11 May 2015

Removing bacterial biofilms could help prevent and treat colon cancers, study suggests

A team led by scientists at The Scripps Research Institute and Johns Hopkins University School of Medicine has uncovered a big clue to how bacteria may promote some colon cancers.

8 May 2015

First patient receives new 'resistance-busting' experimental skin cancer drug

A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor - a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.

6 May 2015

CANCER-ID consortium aims to set up standard procedures for clinical validation of blood-based biomarkers

Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free DNA (cfDNA), circulating tumor DNA (ctDNA) and microRNAs (miRNAs) are potential indicators for the tumor burden of patients living with cancer.

30 Apr 2015

Birmingham City University event to focus on digital future of NHS

The digital future of the NHS will be the focus of a free Birmingham City University event next week. 'Healthcare in a Digital Age' takes place on Thursday 30 April and will see innovators Edward Miller and Robin Vickers lead discussions on the digitisation of patient information and the integration of services giving patients more control over their healthcare.

25 Apr 2015

Study: Cancer rates in HCV patients significantly increase compared to non-HCV cohort

Results announced today at The International Liver Congress 2015 show that cancer rates in patients with the hepatitis C virus (HCV) were significantly increased compared to the non-HCV cohort. The researchers suggest an extrahepatic manifestation of HCV may be an increased risk of cancer.

25 Apr 2015

Study: Childhood cancer survivors need better care throughout their lives

Children with cancer have a good chance of surviving the disease--today more than 80 percent survive because of advances in treatment and care. However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health-related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.

22 Apr 2015

Men with prostate cancer benefit from BRCA-targeting drug

Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday).

22 Apr 2015

Medical University of Vienna study supports use of ANGLE's Parsortix system for ovarian cancer study

ANGLE plc, the specialist medtech company, is delighted to announce that the Medical University of Vienna, one of its key opinion leaders, has published highly encouraging results in support of the use of ANGLE's Parsortix system in the detection of ovarian cancer.

21 Apr 2015

Study attributes mild cognitive defects in women to post-traumatic stress induced by cancer diagnosis

Breast cancer patients often display mild cognitive defects even before the initiation of chemotherapy. A new study by Ludwig-Maximilians-Universitaet in Munich researchers now attributes the syndrome to post-traumatic stress induced by diagnosis of the disease.

21 Apr 2015

UNM Cancer Center enrolls first patient in phase 3 international clinical trial for kidney cancer vaccine

The University of New Mexico Cancer Center recently enrolled its first patient in a phase 3 international clinical trial to test a personalized vaccine against metastatic kidney cancer. Kidney cancer has proven particularly difficult to treat with chemotherapy, and numerous attempts to create a kidney cancer vaccine have not improved survival rates.

20 Apr 2015

CAP pathologist shares four tips for women with breast cancer

For any woman, a diagnosis of breast cancer can be frightening. But as Rita Wilson's recent experience shows, engaging with the keystone of the diagnosis - the pathology report - can be critical in achieving good outcomes. Informed by rigorous scientific processes, training and team discussion, pathology reports identify a diagnosis, help indicate the right providers for a patient's care team and shape treatment plans.

20 Apr 2015

Non-vigorous walking may help prostate cancer survivors reduce damaging side effects

Walking at an easy pace for about three hours every week may be just enough physical activity to help prostate cancer survivors reduce damaging side effects of their treatment, according to a new Northwestern Medicine study.

16 Apr 2015

Veracyte launches new genomic test to improve lung cancer diagnosis

Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.

16 Apr 2015

iCardiac launches industry-first full risk-sharing program for cardiac safety studies

iCardiac Technologies, a market and scientific leader in the conduct of cardiac safety assessments, announced today that it has launched the industry’s first full risk-sharing program for Thorough QT studies. Leveraging its innovative High Precision QT™ methodology for analyzing ECG waveforms, iCardiac’s program guarantees to sponsors that one of two desirable outcomes will be achieved.

14 Apr 2015

Innovative way to educate healthcare professionals on improving nutrition for cancer survivors

Stories involving cancer and its devastating consequences are a frequent occurrence in the news. We are constantly being told which foods may cause cancer, and which may prevent it, but how much is fact, and how much is fiction is often in dispute. The same is true for cancer survivors trying to find reliable nutritional information which will help them to improve their quality of life and prevent future relapses.

13 Apr 2015

Cancer Diagnosis News and Research

Men with asthma less likely to develop lethal prostate cancer

Managing cancer at work: Johns Hopkins launches new service for all employees

Childhood cancer survivors more likely to be obese than healthy peers

Leicester research team identifies potential new targets for cancer treatments

The Project Data Sphere® initiative achieves 1st year milestones

Removing bacterial biofilms could help prevent and treat colon cancers, study suggests

First patient receives new 'resistance-busting' experimental skin cancer drug

CANCER-ID consortium aims to set up standard procedures for clinical validation of blood-based biomarkers

Birmingham City University event to focus on digital future of NHS

Study: Cancer rates in HCV patients significantly increase compared to non-HCV cohort

Study: Childhood cancer survivors need better care throughout their lives

Men with prostate cancer benefit from BRCA-targeting drug

Medical University of Vienna study supports use of ANGLE's Parsortix system for ovarian cancer study

Study attributes mild cognitive defects in women to post-traumatic stress induced by cancer diagnosis

UNM Cancer Center enrolls first patient in phase 3 international clinical trial for kidney cancer vaccine

CAP pathologist shares four tips for women with breast cancer

Non-vigorous walking may help prostate cancer survivors reduce damaging side effects

Veracyte launches new genomic test to improve lung cancer diagnosis

iCardiac launches industry-first full risk-sharing program for cardiac safety studies

Innovative way to educate healthcare professionals on improving nutrition for cancer survivors

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News